Related Experiment Video
Updated: Jun 13, 2025

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
Queen garnet plum juice supplementation does not provide additional cognitive benefits over a group-based memory
Naomi May1, Zoe Fitzgerald2, Samantha Broyd2
1Molecular Horizons and School of Medical, Indigenous and Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, New South Wales, Australia.
Abstract:
Research suggests a role for inflammation and oxidative stress in mild cognitive impairment (MCI) and its progression. Evidence suggests anthocyanin-rich foods may reduce inflammation and oxidative stress and improve cognition but benefits in MCI are unclear. Therefore, it was hypothesized that daily consumption of anthocyanin-rich Queen Garnet Plum (QGP) juice would improve cognition, mood and blood pressure in people with MCI. Participants diagnosed with MCI (N = 42) participated in a double-blind, randomized controlled trial. Participants were administered either QGP juice or apricot juice (comparator) daily for 8-weeks and participated in a 6-week group-based memory program. Cognitive function was assessed using a battery of cognitive tests, including the Rey Auditory Verbal Learning Test (RAVLT), Complex Figure Test (CFT), Royal Prince Alfred-Prospective Memory Test (RPA-ProMem), and Comprehensive Assessment of Prospective Memory self-report (CAPM-self). Mood and blood pressure were also measured pre- and post-intervention. There was a significant effect of TIME for total RAVLT (P = .028, η2 = .12), CFT-recall (P = .036, η2 = .11), RPA-ProMem (P < .001, η2 = .28), and CAPM-self (P = .007, η2 = .22) scores. There was a non-significant trend towards an interaction for CFT-recall (p = .063, η2 = .09), where Bonferroni adjusted pairwise comparisons showed that the QGP group, but not comparators, had significantly improved CFT-recall scores (QGP: +13.93%, P = .007; comparators: +0.84%, P = .855). Overall, QGP consumption during a group-based memory rehabilitation program did not result in additional cognitive benefits in older adults with MCI. This trial was registered at the Australian New Zealand Clinical Trials Registry as ACTRN12618001184268.
Related Concept Videos
Cognitive Development During Adulthood
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment

